DAVID JOHN EMANUEL
Medical Practice in Tenafly, NJ
License number
New Jersey 25MA07569600
Issued Date
Apr 21, 2003
Expiration Date
Jun 30, 2009
Category
Medical Examiners
Type
Medical Doctor
Address
Address
Tenafly, NJ
Professional information
Method Comprising Irinotecan For Treatment Of Breast Cancer
US Patent:
2004026, Dec 30, 2004
Filed:
Apr 26, 2004
Appl. No.:
10/832794
Inventors:
Langdon Miller - Lebanon NJ, US
David Emanuel - Tenafly NJ, US
James McGovren - Kalamazoo MI, US
Larry Schaaf - Dublin OH, US
Sumant Ramachandra - East Brunswick NJ, US
David Emanuel - Tenafly NJ, US
James McGovren - Kalamazoo MI, US
Larry Schaaf - Dublin OH, US
Sumant Ramachandra - East Brunswick NJ, US
International Classification:
A61K031/7072, A61K031/704, A61K031/4745
US Classification:
514/034000, 514/283000, 514/050000
Abstract:
The present invention relates to a method for treating locally advanced or metastatic breast cancer in a patient who demonstrated failure of prior treatment with an anthracycline, a taxane and a fluoropyrimidine, which comprises administering a therapeutically effective amount of irinotecan.
Methods For Treating Proliferative Diseases
US Patent:
2002015, Oct 17, 2002
Filed:
Feb 5, 2002
Appl. No.:
10/067448
Inventors:
David Emanuel - Tenafly NJ, US
Craig Tendler - Teaneck NJ, US
Craig Tendler - Teaneck NJ, US
Assignee:
Schering Corporation
International Classification:
A61K031/704, A61K009/127
US Classification:
514/034000, 424/450000
Abstract:
Methods for treating proliferative diseases, especially breast cancers, comprising administering (1) a therapeutically effective amount of a liposomal anthracycline composition in association with (2) a therapeutically effective amount of an antibody directed against the extracellular domain of a growth factor receptor and optionally in association with (3) a therapeutically effective amount of an additional antineoplastic agent, are disclosed.
Method Of Treating Multiple Myeloma
US Patent:
2004026, Dec 30, 2004
Filed:
May 18, 2004
Appl. No.:
10/847847
Inventors:
David Emanuel - Tenafly NJ, US
Sumant Ramachandra - East Brunswick NJ, US
Sumant Ramachandra - East Brunswick NJ, US
International Classification:
A61K031/4745
US Classification:
514/283000
Abstract:
Multiple myeloma can be treated by administration of irinotecan combined with revimid. The present invention includes methods of treating multiple myeloma by administering the combination of irinotecan and revimid, as well as pharmaceutical kits.